Cargando…

The Impact of Young Age for Prognosis by Subtype in Women with Early Breast Cancer

Young age (≤40 years) use to be considered an independent risk factor for the prognosis of women with early-stage breast cancer. We conducted a retrospective analysis to investigate this claim in a population of young patients who were stratified by molecular subtype. We identified 2,125 women with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lian, Weibin, Fu, Fangmeng, Lin, Yuxiang, Lu, Minjun, Chen, Boyang, Yang, Peidong, Zeng, Bangwei, Huang, Meng, Wang, Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599495/ https://www.ncbi.nlm.nih.gov/pubmed/28912475 http://dx.doi.org/10.1038/s41598-017-10414-x

Ejemplares similares

Subtype-specific associations between breast cancer risk polymorphisms and the survival of early-stage breast cancer
por: Fu, Fangmeng, et al.
Publicado: (2018)

Evaluating the benefits and adverse effects of an enthracycline-taxane-capecitabine combined regimen in patients with early breast cancer
por: Zhang, Jiantang, et al.
Publicado: (2017)

Effect of node status on breast cancer survival by subtype: a single-center retrospective cohort study
por: Lian, Weibin, et al.
Publicado: (2020)

Dual HER2 Blockade versus a Single Agent in Trastuzumab-Containing Regimens for HER2-Positive Early Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Yu, Liuwen, et al.
Publicado: (2020)

The precision relationships between eight GWAS-identified genetic variants and breast cancer in a Chinese population
por: Chen, Yazhen, et al.
Publicado: (2016)

Genetic variants in long noncoding RNA H19 contribute to the risk of breast cancer in a southeast China Han population
por: Lin, Yuxiang, et al.
Publicado: (2017)

Different prognosis by subtype in the early mucinous breast cancer: a SEER population-based analysis
por: Lian, Weibin, et al.
Publicado: (2020)

A ceRNA network-mediated over-expression of cuproptosis-related gene SLC31A1 correlates with poor prognosis and positive immune infiltration in breast cancer
por: Lian, Weibin, et al.
Publicado: (2023)

Evaluating the Survival Benefit Following Ovarian Function Suppression in Premenopausal Patients with Hormone Receptor Positive Early Breast Cancer
por: Qiu, Lin, et al.
Publicado: (2016)

Transcriptional Expressions of CXCL9/10/12/13 as Prognosis Factors in Breast Cancer
por: Li, Yan, et al.
Publicado: (2020)

Associations of Two Common Genetic Variants with Breast Cancer Risk in a Chinese Population: A Stratified Interaction Analysis
por: Lin, Yuxiang, et al.
Publicado: (2014)

High leukocyte mitochondrial DNA copy number contributes to poor prognosis in breast cancer patients
por: Zhang, Wenzhe, et al.
Publicado: (2023)

Identifying Two Common Types of Breast Benign Diseases Based on Multiphoton Microscopy
por: Wu, Yan, et al.
Publicado: (2018)

The association between plasma chemokines and breast cancer risk and prognosis: A mendelian randomization study
por: Yu, Xingxing, et al.
Publicado: (2023)

Polymorphisms of long non-coding RNA HOTAIR with breast cancer susceptibility and clinical outcomes for a southeast Chinese Han population
por: Lin, Yuxiang, et al.
Publicado: (2017)

LncRNA PCIR Is an Oncogenic Driver via Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast Cancer
por: Guo, Wenhui, et al.
Publicado: (2021)

A nomogram prediction for the survival of patients with triple negative breast cancer
por: Lin, Yuxiang, et al.
Publicado: (2018)

Survival following radiotherapy in young women with localized early‐stage breast cancer according to molecular subtypes
por: Liu, Qi‐Qi, et al.
Publicado: (2019)

Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis
por: Lin, Yuxiang, et al.
Publicado: (2020)

Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor–Positive Human Epidermal Growth Factor Receptor-2–Negative Early Breast Cancer Without Chemotherapy
por: Fu, Fangmeng, et al.
Publicado: (2022)

Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis
por: Wang, Chuan, et al.
Publicado: (2013)

Comparison of the Gut Microbiota in Patients with Benign and Malignant Breast Tumors: A Pilot Study
por: Yang, Peidong, et al.
Publicado: (2021)

Occurrence of breast cancer subtypes in adolescent and young adult women
por: Keegan, Theresa HM, et al.
Publicado: (2012)

Identification of Aging and Young Subtypes for Predicting Colorectal Cancer Prognosis and Immunotherapy Responses
por: Tan, Lulu, et al.
Publicado: (2023)

Loco-regional recurrence trend and prognosis in young women with breast cancer according to molecular subtypes: analysis of 1099 cases
por: Li, Yang, et al.
Publicado: (2021)

Clinical application of artificial neural network (ANN) modeling to predict BRCA1/2 germline deleterious variants in Chinese bilateral primary breast cancer patients
por: Li, Yan, et al.
Publicado: (2022)

Genetic and lifestyle factors for breast cancer risk assessment in Southeast China
por: Zou, Shuqing, et al.
Publicado: (2023)

HER2 copy number quantification in primary tumor and cell-free DNA provides additional prognostic information in HER2 positive early breast cancer
por: Chen, Xiaobin, et al.
Publicado: (2022)

The Prognostic Impact of Molecular Subtypes and Very Young Age on Breast Conserving Surgery in Early Stage Breast Cancer
por: Ordu, Cetin, et al.
Publicado: (2016)

Computer-assisted quantification of tumor-associated collagen signatures to improve the prognosis prediction of breast cancer
por: Xi, Gangqin, et al.
Publicado: (2021)

Reproductive risk factors associated with breast cancer in young women by molecular subtype
por: Ruddy, Kathryn J., et al.
Publicado: (2022)

Characteristics and prognostic values of traditional pathological parameters and advanced molecular subtypes in women in Beijing with operable breast cancer: a retrospective analysis
por: Li, Qin, et al.
Publicado: (2018)

Subtype-specific circadian clock dysregulation modulates breast cancer biology, invasiveness, and prognosis
por: Hammarlund, Jan A, et al.
Publicado: (2023)

The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis
por: Kim, Hee Jeong, et al.
Publicado: (2021)

Luminal B subtype: A key factor for the worse prognosis of young breast cancer patients in China
por: Tang, Li-Chen, et al.
Publicado: (2015)

Management of young women with early breast cancer
por: Poggio, Francesca, et al.
Publicado: (2018)

DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer Patients
por: Wu, Zeng-Hong, et al.
Publicado: (2021)

Upregulated Long Non-Coding RNA LL22NC03-N64E9.1 Promotes the Proliferation and Migration of Human Breast Cancer Cells by Silencing Kruppel-Like Factor 2 Expression
por: Lian, Weibin, et al.
Publicado: (2020)

Invasive lobular carcinomas of the breast--the prognosis of histopathological subtypes.
por: du Toit, R. S., et al.
Publicado: (1989)

Metaplastic breast cancer: Treatment and prognosis by molecular subtype
por: Hu, Jin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qrjdevi7p3d2a3ve1p7pg92g2h